Studying multi-omics data for urinary tumor diagnosis and treatment
Part of Cancer, Kidney & urinary clinical trials.
This trial collects and analyzes imaging, lab tests, and tissue samples from people with bladder, kidney, or prostate cancer. The goal is to see how combining these different types of information can improve diagnosis and treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for bladder, kidney, or prostate cancer at Wuhan Union Hospital between January 2024 and January 2026
- You are 18 years or older
- You have had a urinalysis, urine cell test, ultrasound, CT, or MRI that suggests one of these cancers
- A biopsy has confirmed your cancer diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how scans (CT or MRI) can help doctors understand the environment around urologic tumors. It may lead to better ways to predict treatment response and outcomes.
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
This study collects samples (blood, urine, tissue) and health information from people with bladder or urinary tract cancers. The goal is to learn more about these cancers to improve detection and treatment in the future.
This study collects a small urine sample around the time of a prostate biopsy to look for chemical “signals” that may explain dangerous prostate cancer behavior. Your results are not shared with you, but the information may help researchers improve understanding and future care.
This study is collecting blood, urine, and tissue samples from people with high-risk non-muscle invasive bladder cancer to help develop better tests for tracking the disease. By participating, you might help improve future monitoring and treatment decisions.
This trial is testing if a simple urine test can help track prostate or bladder cancer over time without needing invasive procedures. It includes five specific patient groups with different stages of these cancers.
Hear when a new Urinary System Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.